Skip to main content

Extraction of raspberry ketone from red raspberry and its intervention in the non-alcoholic fatty liver disease

Abstract

Nonalcoholic fatty liver disease (NAFLD) is characterized by diffused hepatocyte bullous fat in the liver, which is not caused by alcohol or drugs like amiodarone and tamoxifen. Presently, no drug is approved for NAFLD treatment. Therefore, it’s important to extract effective components from natural plants to alleviate NAFLD. In this study, we extracted and purified raspberry ketone, a natural phenolic compound from red raspberry (Rubus ideaus L.) by an ultrasonic-assisted ethanol extraction method. The structure of red raspberry ketone (RRK) was determined using Fourier-transform infrared spectroscopy and the purity of RRK was found as 80.06 ± 1.19%. After 28 days of intragastric administration of RRK, the bodyweight of NAFLD model rats decreased significantly (p < 0.05). Besides, the levels of low-density lipoprotein cholesterol, total cholesterol, and total triglyceride (TG) decreased and the content of high-density lipoprotein cholesterol in serum increased drastically. Moreover, the level of liver damage indicators (aspartate aminotransferase, alanine aminotransferase, and alkaline phosphatase) and the levels of glucose, insulin, free-fatty acid, tumor necrotic factor-α in the liver decreased distinctly. The levels of TG and malondialdehyde in the liver decreased, whereas the levels of superoxide dismutase, total glutathione, and glutathione peroxidase drastically increased. We also found that RRK reduced the uneven size of liver cells and blurred boundaries of hepatic lobules, and alleviated hepatic steatosis and inflammation caused by NAFLD. We inferred that RRK could relieve NAFLD progression by regulating glucose and lipid metabolism and alleviating oxidative stress in vivo. This study sheds new light on the use of RRK as a functional food for NAFLD prevention.

Introduction

Non-alcoholic fatty liver disease (NAFLD) is defined as hepatic steatosis characterized by the absence of other pathogenic factors of liver disease, such as chronic viral hepatitis and the presence of hepatic fat accumulation (> 5%) [1]. The pathogenesis of NAFLD is complex. Metabolic abnormalities caused by excess fat in the liver and the development of inflammation can trigger NAFLD. At present, the “two-hit” theory is a relatively comprehensive explanation of the pathogenesis of NAFLD [2, 3]. The theory states that the first hit is caused by abnormal lipid intake or abnormal mitochondrial function in the body because of obesity or type 2 diabetes, which causes massive lipid accumulation in the hepatocytes. This results in triglyceride deposition in the liver or steatosis, which increases the chance of liver damage mediated by the “second hit” [4]. The “second hit” is caused by oxidative stress and lipid peroxidation in the hepatocytes, which causes mitochondrial dysfunction, production of inflammatory mediators, and activation of hepatic stellate cells, resulting in inflammatory necrosis and fibrosis of the hepatocytes [5]. Recently, some researchers also found the multiple hit theory was also another explanation of the pathogenesis of NAFLD, such hits were associated with insulin resistance and abnormal glucolipid metabolism, which is harmful to our health [6, 7]. NAFLD has a high incidence in developed industrial countries in recent years [8]. NAFLD treatment consists mainly of lifestyle changes and adjunctive medication. However, no definitive drug is available for the NAFLD-treatment [9]. Drugs that are used for the NAFLD-treatment include statins and fibrates, which can alleviate NAFLD by regulating abnormalities in lipid metabolism. However, these drugs have some side effects such as gastrointestinal discomfort and impairment of liver and kidney function [10]. To address this concern, some studies have focused on the effectiveness of the nature bioactive compounds such as Lee et al.’s and Shah et al.’s studies [11, 12]. Moreover, Li et al. also reported that a plant based bioactive compounds, eugenol, had a positive effect on NAFLD via regulate lipid metabolism [13]. Similarly, another study also reported that an extract from cranberry can improve insulin sensitivity to lower blood glucose levels and increase antioxidant and anti-inflammatory activities in vivo [14].

Red raspberry (Rubus ideaus L.) is a natural plant that has a distinctive red color and a delicious flavor that is popular among consumers. Red raspberry is recommended worldwide by the Food and Agriculture Organization of the United Nations as one of the key fruits of the third generation, i.e. the fruits distributed in the wild forest area which has not been exploited and some newly developed special fruits. [15]. Previous study has reported that red raspberry is rich in active ingredients, such as ellagic acid and anthocyanin, which has antioxidant, anti-inflammatory, and anti-cancer properties [16]. Red raspberry can also improve glucolipid metabolism [17]. Luo et al. reported that the consumption of red raspberries every day markedly reduces hepatic lipid accumulation in vivo. Raspberry ketone is a group of natural phenolic compounds in red raspberry [18]. Pure raspberry ketone is a translucent white short needle-like crystal powder, which is a class of natural phenolic compounds in red raspberry. Raspberry ketone and esters, aldehydes, alcohols, terpenes, ketones and pyrazines together form a complex mixture of volatile aroma components of red raspberries. Raspberry ketone can regulate body weight, prevent obesity, and alleviate obesity-induced hyperlipidemia in vivo [19]. Besides, raspberry ketones can increase insulin secretion and possesses hypoglycemic properties [20]. However, only a few studies have focused on the raspberry ketones extracted from red raspberry and determined their ability to modulate glucose and lipid metabolism to alleviate NAFLD. In the present study, we extracted and purified raspberry ketones from red raspberries and characterized their structure. We hypothesized that raspberry ketones from red raspberries can alleviate NAFLD. Moreover, we also investigated its effects in NAFLD model rats. We believe this study can provide a basis for the application of functional foods in the regulation and treatment of NAFLD.

Materials and methods

Materials and reagents

Red raspberry (Rubus ideaus L.) was obtained from ShangZhi District, Harbin City, Heilongjiang Province. AB-8 macroporous resin and polyamide resin were purchased from Macklin Reagent Company (Shanghai, China). Other reagents were of analytical grade.

Preparation of red raspberry ketones

Firstly, 20 g of red raspberry was added to 3000 mL of anhydrous ethanol (85%, v/v) and kept at 40 °C for 50 min for ultrasonic-assisted extraction. Afterward, the extract was purified by sequential elution using an AB-8 macroporous resin and polyamide resin. It was then freeze-dried under vacuum conditions to obtain purified red raspberry ketone (RRK).

Purity identification and structural characterization of RRK

The purity of RRK was determined by gas chromatography–mass spectroscopy (GC–MS). Briefly, RRK was dissolved in ethanol (0.1 mg/mL), and the GC–MS analysis conditions were as follows: An Agilent HP-5 (5%-phenyl)-methyl polysiloxane non-polar column with a hydrogen flame ionization detector (FID) was used. The injection port temperature was 250 °C, and the detector temperature was 280 °C. The column oven temperature was 220 °C, the carrier gas was N2, and the split flow was 60:1, and the sample injection volume was 10 μL.[21].

The structure of RRK was detected by a Fourier transform infrared (FT-IR) spectrophotometer (Perkin-Elmer 2000, Perkin Elmer Company, USA) by KBr pressing method. The wavelength range was 500–4000 cm–1.

Effect of RRK on NAFLD in vivo

Animals and treatments

A total of 64 specific pathogen-free Wistar rats (male, 220 ± 10 g) were purchased from the Changchun Yisi Experimental Animal Center (production license number, Scxk(Ji)-2011–0004; certificate number, 201,500,010,264) and kept at 23 ± 2 °C with a relative humidity of 40–70%. All the rats were provided with natural light and ad libitum access to food and water. After acclimatization for 7 days, 8 rats were selected in the control group (NC) and fed with a normal diet, whereas the remaining rats were fed with a high-fat diet. After continuous feeding for 28 days, the presence of heavy rats with serum levels of total triglyceride (TG) and total cholesterol (TC) higher than those of the NC group was an indicator of successful modeling. Then, the NAFLD model rats were randomly divided into the following five groups: high fat model group (MC, n = 10 whose rats received intragastric administration of physiological saline solution), raspberry ketone high dose group (HRK, n = 10 whose rats received intragastric administration of RRK for 200 mg·kg−1·d−1), raspberry ketone medium-dose group (MRK, n = 10, whose rats received intragastric administration of RRK for 100 mg·kg−1·d−1), raspberry ketone low dose group (LRK, n = 10, whose rats received intragastric administration of RRK for 50 mg·kg−1·d−1), and positive control group (PC, n = 10, whose rats received intragastric administration of metformin for 150 mg·kg−1·d−1 and Tiopronin for 40 mg·kg−1·d−1). After 28 days of treatment, the rats in each group underwent fasting for 12 h. They were weighed and then sacrificed. The serum of the rats was extracted from the blood by centrifugation at 4 °C (3,000 rpm for 10 min). The liver tissue in each rat was also obtained and divided into two sections. One section was used for histopathological staining and the other section was homogenized for testing biochemical indicators [22, 23]. All procedures used in this experiment were approved by the Institutional Animal Care (the Animal Protection) and Use Committee of the Harbin University of Commerce.

Evaluation of biochemical parameters in the serum

The biochemical parameters, such as high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), triglyceride (TG), alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (AKP), glucose (GLU), free fatty acid (FFA) and tumor necrosis factor-α (TNF-α), in serum, were evaluated using standard kits (Nanjing Jiancheng Bioengineering Institute Co., Ltd, Nanjing, China).

Evaluation of biochemical parameters in the liver

The biochemical parameters, such as triglyceride (TG), malondialdehyde (MDA), superoxide dismutase (SOD), total glutathione (T-GSH), and glutathione peroxidase (GSH-Px), in the liver tissue was evaluated using standard kits (Nanjing Jiancheng Bioengineering Institute Co., Ltd, Nanjing, China).

Hematoxylin and eosin (H&E) staining of the liver

H&E staining was performed to determine the effect of raspberry ketones on liver histopathology in vivo. The fixed liver tissues were embedded, sectioned, stained, and sealed, and finally, each group of tissues was microscopically photographed.

Statistical analysis

The experimental data were analyzed using SPSS 17.0 software (SPSS, Chicago, IL, USA) for variance calculation and significance analysis. The data are expressed as mean ± standard deviation (mean ± SD), and the LSD method was performed for multiple comparisons between groups. All the figures were drawn using Origin 2018 (OriginLab Corp., MA, USA).

Results and discussion

Structure characterization of red raspberry ketones

The FT-IR spectra of RRK obtained by ultrasonic-assisted ethanol are shown in Fig. 1A We found that the spectrum of RRK was in line with the standard sample. We observed a strong and wide absorption peak at 3371.21 cm–1, which was consistent with the characteristic absorption peak range of hydroxyl (3000–3750 cm–1). We also observed an absorption peak around 1550 cm–1, which was associated with a benzene ring. We inferred that a phenolic hydroxyl structure was present in RRK [24, 25].

Fig. 1
figure 1

Structure characterization of RRK. A: The Fourier transform infrared spectroscopy spectra of red raspberry ketone (RRK), B: Standard curve of raspberry ketone, C: Gas chromatogram of raspberry ketone standard (10 μg/mL), and D: Gas chromatogram of RRK (10 μg/mL)

The spectra of raspberry ketone standard obtained from GC–MS are shown in Fig. 1C The peak time of the standard was 4.685 min. The standard curve was Y = 415.14X − 53.714, R2 = 0.9990 (Fig. 1B). As shown in Fig. 1C–D, the shape of the RRK chromatographic peak was similar to the raspberry ketone standard, and the peak time was 4.699 min. The purity of RRK was 80.06 ± 1.19%.

Effect of RRK on the biochemical indicators in serum

As shown in Fig. 2A, the body weight of rats in the high-fat diet group was significantly increased than those in the normal-diet group after they were fed for 4 weeks (260.12 ± 6.41 g vs 288.31 ± 16.60 g, P < 0.01). The HDL-C levels decreased remarkably, and the LDL-C, TC, and TG levels increased significantly (P < 0.05), which indicated that the NAFLD modeling was successful (Fig. 2B) [26].

Fig. 2
figure 2

Changes of rats after modeling. A: Changes in body weight after modeling; B: Changes in serum lipid level

During the administration period, the rats administered with RRK by oral gavage were more stable, moved freely, and had a better mental state and a shiny coat. Their diet and water intake were normal, and they did not show any abnormalities. However, the rats in the MC group which didn’t administered with RRK had a darker and rougher coat because of the metabolic disorders in liver caused by NAFLD.

After 28 days of treatment, the body weight of rats in the MC group increased significantly (P < 0.05) than those in the NC group. The weight of rats in the PC, HRK, MRK, and LRK groups decreased significantly (P < 0.05) than those in the MC group. This indicated that RRK can decrease the body weight of NAFLD model rats (Fig. 3A). We also observed that the HDL-C levels of the NAFLD model rats increased, and the LDL-C, TC, and TG levels remarkably decreased after the treatment with RRK. (Fig. 3B–E, P < 0.05). This indicated that RRK can promote the breakdown and metabolism of lipids in the serum, and the ability to transport cholesterol and triglycerides was improved in the NAFLD model rats. Thus, RRK has a positive effect on the removal of the deposited lipids from the arterial wall of blood vessels.

Fig. 3
figure 3

Effect of red raspberry ketone (RRK) on body weight and the level of lipid biochemical indicators in serum. A: Effects of red raspberry ketone (RRK) on body weights of rats. BE: Effects of RRK on TC (B), total triglyceride (TG) (C), low-density lipoprotein cholesterol (LDL-C) (D), and high-density lipoprotein cholesterol (HDL-C) (E) in serum of rats. (*P < 0.05, **P < 0.01 compared with NC; #P < 0.05, ##P < 0.01 compared with MC; $P < 0.05 compared with PC)

Some studies have also found similar results. Reem et al. found Garcinia cambogia (Garcinia gummi-gutta) and raspberry ketone could alleviate hepatocyte inflammation, fatty changes, and oxidative stress caused by a high-fat fructose diet [27]. Moreover, Wang et al. also found that raspberry ketone could protect the liver and reduce fat in the body against nonalcoholic steatohepatitis [28].

AST and ALT were released from the liver after its injury, which reflected the level of liver injury. As shown in Fig. 4A–B, the rats in the MC group showed a large increase in AST levels than those in the NC group (P < 0.01), whereas the AST levels decreased in the PC and RRK groups than those in the MC group (P < 0.01). Moreover, the ALT levels in the MC group also exhibited a remarkable improvement compared with those in the normal group (P < 0.01), whereas the ALT levels in the PC and RRK treatment groups, showed a highly significant decrease compared with those in the MC group (P < 0.01). Thus, RRK can decrease the levels of ALT and AST in serum. We inferred that RRK may repair necrotic hepatocytes to a certain extent and might be able to decrease the permeability of the cell membrane. Overall, RRK can inhibit the further development of NAFLD, which has certain significance in its clinical prevention. These results are consistent with some previous studies. Faheem et al. reported that cranberry extract can decrease ALT and AST levels in serum and can retard the progression of NAFLD [14]. The extract from pomegranate peel can decrease the levels of ALT and AST and can be used in the treatment of NAFLD [29]. AKP is overproduced when the liver cells are damaged. Compared with the NC group, the AKP level in the MC group significantly increased (P < 0.01), and the AKP level in the PC group and the groups with different doses of RRK significantly decreased (Fig. 4C, P < 0.01) compared with the MC group. This indicated that RRK can effectively reduce AKP levels in serum and control the abnormal metabolism and impaired excretion of AKP from the body. These results were consistent with those of other studies [30, 31]. Hence, the results showed that RRK can prevent the inflammatory response in the liver to alleviate NAFLD.

Fig. 4
figure 4

Effect of red raspberry ketone (RRK) on the level of liver damage indicator in serum. AC: Effects of red raspberry ketone (RRK) on aspartate aminotransferase (AST) A, alanine aminotransferase (ALT) B and alkaline phosphatase (AKP) C in serum of rats. (*P < 0.05, **P < 0.01 compared with NC; #P < 0.05, ##P < 0.01 compared with MC; $P < 0.05 compared with PC)

Some studies have reported that abnormal lipid metabolism can trigger an increase in the blood glucose levels of the body and insulin resistance can be present, which can contribute to the risk of type 2 diabetes such as Shah et al.’s and Koh et al.’s studies [32, 33]. Based on this, we speculated that RRK can decrease glucose levels. We found that the glucose levels in the MC group increased significantly compared with those in the NC group (P < 0.01), and the model rats treated with different doses of RRK had decreased glucose levels in the serum, which was consistent with the results of the PC group. The results indicated that RRK can inhibit the secretion of blood glucose in vivo (Fig. 5A). Insulin (INS) is a major hormone that lowers blood glucose levels and promotes glycogen synthesis. An abnormal increase in blood glucose levels leads to an increase in the compensatory secretion of INS. The levels of INS increased significantly in the MC group, and this phenomenon was relieved remarkably in the RRK group in a dose-dependent manner (Fig. 5B, P < 0.05). This finding is consistent with those of other studies. A plant extract, procyanidin B2, can improve insulin resistance and glucose–lipid metabolism during NAFLD and reduce blood glucose levels [34]. You et al. also reported that oat β-glucan can relieve abnormal lipid metabolism, which was associated with a decrease in blood glucose levels [35]. In this study, we found that RRK can decrease the glucose and insulin levels in rats, which indicated that RRK can also increase glucose metabolism in vivo. Therefore, we hypothesized that RRK also has a positive effect on diabetes.

Fig. 5
figure 5

Effect of red raspberry ketone (RRK) on the level of glucose (GLU) A, insulin (INS) B, free-fatty acid (FFA) C, and tumor necrotic factor (TNF)-α D in serum. *P < 0.05, **P < 0.01 compared with NC; #P < 0.05, ##P < 0.01 compared with MC; $P < 0.05 compared with PC

FFA concentration in the blood serum is associated with the glycolipid metabolism and endocrine function in vivo and indicates the degree of liver injury. Figure 5C showed that FFA levels were significantly higher in the MC group than those in the NC group (P < 0.01) and were significantly lower in the rats treated with RRK, which was similar to the results of the PC group. High FFA can cause an inflammatory response, which in turn leads to metabolic disturbances in the body. TNF-α is an important indicator of the inflammatory response, which was significantly higher in the MC group than in the normal rats (P < 0.01). After RRK treatment, TNF-α levels in serum indicated a significant decrease (Fig. 5D, P < 0.05). These results suggested that RRK can decrease the production of TNF-α in the adipose tissue. Ngamlerst et al. reported that Maoberry extracts decreased TNF-α levels in the NAFLD model rats and decreased lipid production [36]. A previous study reported that excessive FFA leads to the overproduction of reactive oxygen species (ROS) and reactive nitrogen species (RNS) [37]. Some studies reported that the increased indicators of the inflammatory response can induce oxidative stress in vivo [38, 39]. We speculated that RRK has a positive effect on lipid metabolism, oxidative stress, and inflammatory response in the liver tissues.

Effect of RRK on the biochemical indicators in the liver

Figure 6A shows some representative indicators of lipid metabolism. Compared with the NC group, the TG levels in the liver were significantly higher in the MC group (P < 0.01), whereas it was markedly decreased (P < 0.01) in the PC, HRK, MRK, and LRK groups. This also showed a certain dose–effect relationship. It indicated that RRK can effectively inhibit the increase of TG and maintain lipid metabolism in the liver of NAFLD rats. This result was consistent with the results of some previous studies [40, 41].

Fig. 6
figure 6

Effect of red raspberry ketone (RRK) on biochemical indicators in liver. AE: Effects of red raspberry ketone (RRK) on total triglyceride (TG) A, malondialdehyde (MDA) B, superoxide dismutase (SOD) C, total glutathione (T-GSH), D and glutathione peroxidase (GSH-Px) (E) in the serum of rats. (*P < 0.05, **P < 0.01 compared with NC; #P < 0.05, ##P < 0.01 compared with MC; $P < 0.05 compared with PC)

To determine whether RRK can alleviate oxidative stress to relieve NAFLD, we evaluated the levels of MDA, SOD, T-GSH, and GSH-Px to determine the antioxidant capacity of the liver (Fig. 6B–E). MDA is a product of lipid peroxidation in the body, which can reflect the degree of lipid peroxidation. This is an indicator of cell damage and biofilm destruction. We found a remarkable increase in the MDA level of the MC group (P < 0.01), which decreased significantly after RRK treatment compared with that of the model group (P < 0.01). Meanwhile, the level of SOD in the serum of the MC group decreased significantly (P < 0.01), which indicated that the ability of NAFLD rats to remove harmful substances decreased during the metabolic process. The level of SOD in the liver increased distinctly after RRK treatment than those in the model group (P < 0.01). Glutathione (T-GSH) is an important antioxidant and free radical scavenger in living organisms. It can bind to harmful substances, such as free radicals and heavy metals and help in their excretion. Glutathione peroxidase (GSH-Px) can decompose lipid hydroperoxides in organisms and inhibit the damage of fatty acids on biofilms. RRK can significantly increase the GSH and GSH-Px levels in NAFLD rats. This suggested that RRK can repair cell damage and biofilm disruption triggered by abnormal lipid metabolism caused by NAFLD. All these findings showed that RRK can improve the antioxidant capacity of NAFLD rats in the liver. Denise et al. reported that the extract of Citrus maxima leaves showed antioxidant activity in the NAFLD model rats, which was consistent with the results of our study [42]. Furthermore, we also speculated that RRK can also have a positive effect on liver morphology.

Morphological observations of the liver

The results of liver pathology staining are shown in Fig. 7. The hepatic tissues of the NC group have a clear and intact structure, along with a certain regularity of cell arrangement and distribution, normal size of hepatocytes, medium-sized nuclei, and a more homogeneous cell body. In the MC group, we observed that the lobules of the liver were heavily damaged, and most cells varied markedly in size and contained a certain amount of lipid droplet vacuolation within the hepatocytes, along with steatosis and fibrosis. Moreover, we observed varying degrees of cellular inflammation with focal necrosis of the glandular follicles, which is consistent with the liver inflammation indicators. After treatment with RRK, the liver lobules were clearer, the hepatic blood sinusoids were more intact, and the hepatic cords were more regularly arranged. We observed no distinct steatosis or inflammatory infiltration. The hepatocytes were more regularly arranged, and fewer intrahepatic lipid droplets were observed in the HRK group. Also, the hepatic cords were more distinctly defined, and the structural integrity of the hepatic lobules was improved more remarkably. These findings were consistent with those of some other reports [43, 44]. These results indicated that RRK has positive therapeutic effects on NAFLD in a dose-dependent manner.

Fig. 7
figure 7

Hematoxylin and eosin (HE) staining results of the liver tissue of rats in each group

Availability of data and materials

All data, models, and code generated or used during the study appear in the submitted article. The data presented in this paper are available on request from the first author and corresponding author.

References

  1. Shang Y, Nasr P, Widman L, Hagström H (2022) Risk of cardiovascular disease and loss in life expectancy in non-alcoholic fatty liver disease. Hepatology. https://doi.org/10.1002/HEP.32519

    Article  PubMed  Google Scholar 

  2. Song Q, Zhang X (2022) The role of gut-liver axis in gut microbiome dysbiosis associated NAFLD and NAFLD-HCC. Biomedicines 10(3):524–524. https://doi.org/10.3390/BIOMEDICINES10030524

    Article  PubMed  PubMed Central  Google Scholar 

  3. Juan P, Marco A, Michael T (2018) Recent Insights into the pathogenesis of nonalcoholic fatty liver disease. Annu Rev Pathol 13(1):321–350. https://doi.org/10.1146/annurev-pathol-020117-043617

    Article  CAS  Google Scholar 

  4. Gross B, Pawlak M, Lefebvre P, Staels B (2017) PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD. Nat Rev Endocrinol 13(1):36–49. https://doi.org/10.1038/nrendo.2016.135

    Article  CAS  PubMed  Google Scholar 

  5. Anstee Quentin M, Day CP (2013) The genetics of NAFLD. Nat Rev Gastroenterol Hepatol 10(11):645–655. https://doi.org/10.1038/nrgastro.2013.182

    Article  CAS  PubMed  Google Scholar 

  6. Daniela M, Evelina M, Claudia F, Manuela C, Cristina M, Minela A, Anca O, Mariana F, Jia G (2020) The intricate relationship between type 2 diabetes mellitus (T2DM), Insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD). J Diabetes Res 2020:3920196–3920196. https://doi.org/10.1155/2020/3920196

    Article  CAS  Google Scholar 

  7. Elena B, Massimo P, Emmanuel A (2016) The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism. https://doi.org/10.1016/j.metabol.2015.12.012

    Article  Google Scholar 

  8. Zobair M, Pegah G, Leyla A, James M, Manirath S, Natsu F, Ying Q, Leah B, Arian A, Fatema N (2019) The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol 71(4):793–801. https://doi.org/10.1016/j.jhep.2019.06.021

    Article  Google Scholar 

  9. Yao H, Qiao Y, Zhao Y, Tao X, Xu L, Yin L, Qi Y, Peng J (2016) Herbal medicines and nonalcoholic fatty liver disease. World J Gastroenterol 22(30):6890–6905. https://doi.org/10.3748/wjg.v22.i30.6890

    Article  PubMed  PubMed Central  Google Scholar 

  10. Galeano D, Li S, Gerstein M, Paccanaro A (2020) Predicting the frequencies of drug side effects. Nat Commun 11(1):4575. https://doi.org/10.1038/s41467-020-18305-y

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Lee S, Jeong S, Park Y, Seo H, You C, Hwang U, Park H, Suh H (2021) Supplementation of non-fermented and fermented goji berry (Lycium barbarum) improves hepatic function and corresponding lipid metabolism via their anti-inflammatory and antioxidant properties in high fat-fed rats. Appl Biol Chem. https://doi.org/10.1186/S13765-021-00642-1

    Article  Google Scholar 

  12. Shah A, Baiseitova A, Kim J, Lee Y, Park K (2022) Inhibition of bacterial neuraminidase and biofilm formation by ugonins isolated from Helminthostachys Zeylanica (L.) Hook. Front Pharmacol 13:890649. https://doi.org/10.3389/FPHAR.2022.890649

    Article  PubMed  PubMed Central  Google Scholar 

  13. Li H, Yuan W, Tian Y, Tian F, Wang Y, Sun X, Gong Y (2022) Eugenol alleviated nonalcoholic fatty liver disease in rat via a gut-brain-liver axis involving glucagon-like Peptide-1. Arch Biochem Biophys 725:109269–109269. https://doi.org/10.1016/J.ABB.2022.109269

    Article  CAS  PubMed  Google Scholar 

  14. Faheem S, Saeed N, El-Naga R, Ayoub I, Azab S (2020) Hepatoprotective effect of cranberry nutraceutical extract in non-alcoholic fatty liver model in rats: impact on insulin resistance and Nrf-2 expression. Front Pharmacol 11:218. https://doi.org/10.3389/fphar.2020.00218

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Jelena J, Jasminka M, Milena M, Mihailo D, Vuk M (2013) Profiling antioxidant activity of two primocane fruiting red raspberry cultivars (Autumn bliss and Polka). J Food Compos Anal 31(2):173–179

    Article  Google Scholar 

  16. Wu T, Yang L, Guo X, Zhang M, Liu R, Sui W (2018) Raspberry anthocyanin consumption prevents diet-induced obesity by alleviating oxidative stress and modulating hepatic lipid metabolism. Food Funct 9(4):2112–2120. https://doi.org/10.1039/c7fo02061a

    Article  CAS  PubMed  Google Scholar 

  17. Luo T, Miranda-Garcia O, Adamson A, Sasaki G, Shay N (2016) Development of obesity is reduced in high-fat fed mice fed whole raspberries, raspberry juice concentrate, and a combination of the raspberry phytochemicals ellagic acid and raspberry ketone. J Berry Res 6(2):213–223. https://doi.org/10.3233/jbr-160135

    Article  CAS  Google Scholar 

  18. Luo T, Miranda-Garcia O, Sasaki G, Shay N (2017) Consumption of a single serving of red raspberries per day reduces metabolic syndrome parameters in high-fat fed mice. Food Funct 8(11):4081–4088. https://doi.org/10.1039/c7fo00702g

    Article  CAS  PubMed  Google Scholar 

  19. Morimoto C, Satoh Y, Hara M, Inoue S, Tsujita T, Okuda H (2005) Anti-obese action of raspberry ketone. Life Sci 77(2):194–204

    Article  CAS  PubMed  Google Scholar 

  20. Reem T, Yousra A, Dalaal M, Hanan S, Nabila N (2019) Raspberry ketone and Garcinia Cambogia rebalanced disrupted insulin resistance and leptin signaling in rats fed high fat fructose diet. Biomed Pharmacother 110:500–509. https://doi.org/10.1016/j.biopha.2018.11.079

    Article  CAS  Google Scholar 

  21. Zhang X, Sandhu A, Edirisinghe I, Burton-Freeman B (2018) An exploratory study of red raspberry (Rubus idaeus L) (poly) phenols/metabolites in human biological samples. Food Funct 9(2):806–818. https://doi.org/10.1039/c7fo00893g

    Article  CAS  PubMed  Google Scholar 

  22. Zou J, Yan C, Wan J (2022) Red yeast rice ameliorates non-alcoholic fatty liver disease through inhibiting lipid synthesis and NF-κB/NLRP3 inflammasome-mediated hepatic inflammation in mice. Chin Med 17(1):17–17. https://doi.org/10.1186/S13020-022-00573-Z

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Duan R, Huang K, Guan X, Li S, Xia J, Shen M, Sun Z, Yu Z (2022) Tectorigenin ameliorated high-fat diet-induced nonalcoholic fatty liver disease through anti-inflammation and modulating gut microbiota in mice. Food Chem Toxicol: an Int J published for the British Industrial Biological Research Association 164:112948–112948. https://doi.org/10.1016/J.FCT.2022.112948

    Article  CAS  Google Scholar 

  24. Scano P (2021) Characterization of the medium infrared spectra of polyphenols of red and white wines by integrating FT IR and UV–Vis spectral data. LWT 2021:147. https://doi.org/10.1016/J.LWT.2021.111604

    Article  Google Scholar 

  25. Lin D, Xiao L, Wen Y, Qin W, Wu D, Chen H, Zhang Q, Zhang Q (2021) Comparison of apple polyphenol-gelatin binary complex and apple polyphenol-gelatin-pectin ternary complex: Antioxidant and structural characterization. LWT. https://doi.org/10.1016/J.LWT.2021.111740

    Article  Google Scholar 

  26. Wang S, Yang F, Shang L, Zhang Y, Zhou Y, Shi X (2019) Puerarin protects against high-fat high-sucrose diet-induced non-alcoholic fatty liver disease by modulating PARP-1/PI3K/AKT signaling pathway and facilitating mitochondrial homeostasis. Phytotherapy research: PTR 33(9):2347–2359. https://doi.org/10.1002/ptr.6417

    Article  CAS  PubMed  Google Scholar 

  27. Reem T, Yousra A, Dalaal M, Hanan S, Nabila N (2019) Raspberry ketone and Garcinia Cambogia rebalanced disrupted insulin resistance and leptin signaling in rats fed high fat fructose diet. Biomed Pharmacother 110:500–509. https://doi.org/10.1016/j.biopha.2018.11.079

    Article  CAS  Google Scholar 

  28. Wang L, Meng X, Zhang F (2012) Raspberry ketone protects rats fed high-fat diets against nonalcoholic steatohepatitis. J Med Food 15(5):495–503. https://doi.org/10.1089/jmf.2011.1717

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Al-Shaaibi S, Waly M, Al-Subhi L, Tageldin M, Rahman M (2016) Ameliorative effects of pomegranate peel extract against dietary-induced nonalcoholic fatty liver in rats. Prev Nutr Food Sci 21(1):14–23. https://doi.org/10.3746/pnf.2016.21.1.14

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Mu J, Tan F, Zhou X, Zhao X (2020) Lactobacillus fermentum CQPC06 in naturally fermented pickles prevents non-alcoholic fatty liver disease by stabilizing the gut-liver axis in mice. Food Funct. https://doi.org/10.1039/d0fo01823f

    Article  PubMed  Google Scholar 

  31. Liu B, Zhang J, Sun P, Yi R, Han X, Zhao X (2019) Raw bowl tea (Tuocha) polyphenol prevention of nonalcoholic fatty liver disease by regulating intestinal function in mice. Biomolecules 9(9):435–435. https://doi.org/10.3390/biom9090435

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Shah A, Yoon S, Kim J, Zhumanova K, Ban Y, Lee K, Park K (2020) Effectiveness of cyclohexyl functionality in ugonins from Helminthostachys zeylanica to PTP1B and α-glucosidase inhibitions. Int J Biol Macromol 165:1822–1831. https://doi.org/10.1016/j.ijbiomac.2020.10.061

    Article  CAS  PubMed  Google Scholar 

  33. Koh Y, Lin Y, Lee P, Lu T, Lin K, Pan M (2020) A multi-targeting strategy to ameliorate high-fat-diet-and fructose-induced (western diet-induced) non-alcoholic fatty liver disease (NAFLD) with supplementation of a mixture of legume ethanol extracts. Food Funct. https://doi.org/10.1039/d0fo01405b

    Article  PubMed  Google Scholar 

  34. Xing Y, Lei G, Wu Q, Jiang Y, Huang M (2019) Procyanidin B2 protects against diet-induced obesity and non-alcoholic fatty liver disease via the modulation of the gut microbiota in rabbits. World J Gastroenterol 25(8):955–966. https://doi.org/10.3748/wjg.v25.i8.955

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. You S, Hu X, Zhao Q, Chen X, Xu C (2013) Oat β-glucan inhibits lipopolysaccharide-induced nonalcoholic steatohepatitis in mice. Food Funct 4(9):1360–1368. https://doi.org/10.1039/c3fo60081e

    Article  CAS  PubMed  Google Scholar 

  36. Ngamlerst C, Udomkasemsab A, Kongkachuichai R, Kwanbunjan K, Chupeerach C, Prangthip P (2019) The potential of antioxidant-rich Maoberry (Antidesma bunius) extract on fat metabolism in liver tissues of rats fed a high-fat diet. BMC Complement Altern Med 19(1):294. https://doi.org/10.1186/s12906-019-2716-0

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Ruiz-Ramírez A, Chávez-Salgado M, Peñeda-Flores J, Zapata E, Masso F, El-Hafidi M (2011) High-sucrose diet increases ROS generation, FFA accumulation, UCP2 level, and proton leak in liver mitochondria. Am J Physiol. Endocrinol Metab 301(6):E1198-207

    Article  PubMed  Google Scholar 

  38. Sutti S, Jindal A, Locatelli I, Vacchiano M, Gigliotti L, Bozzola C, Albano E (2014) Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH. Hepatology (Baltimore, Md) 59(3):886–897. https://doi.org/10.1002/hep.26749

    Article  CAS  PubMed  Google Scholar 

  39. Petrescu M, Vlaicu S, Ciumărnean L, Milaciu M, Mărginean C, Florea M, Vesa Ș, Popa M (2022) Chronic inflammation—A link between nonalcoholic fatty liver disease (NAFLD) and dysfunctional adipose tissue. Medicina 58(5):641–641. https://doi.org/10.3390/MEDICINA58050641

    Article  PubMed  PubMed Central  Google Scholar 

  40. Pfohl M, DaSilva N, Marques E, Agudelo J, Liu C, Goedken M, Slitt A, Seeram N, Ma H (2020) Hepatoprotective and anti-inflammatory effects of a standardized pomegranate (Punica granatum) fruit extract in high fat diet-induced obese C57BL/6 mice. Int J Food Sci Nutr 72(4):11–12. https://doi.org/10.1080/09637486.2020.1849041

    Article  CAS  Google Scholar 

  41. Chen Z, Liu F, Zheng N, Guo M, Bao L, Zhan Y, Zhang M, Zhao Y, Guo W, Ding G (2019) Wuzhi capsule (Schisandra Sphenanthera extract) attenuates liver steatosis and inflammation during non-alcoholic fatty liver disease development. Biomed Pharmacother 110:285–293. https://doi.org/10.1016/j.biopha.2018.11.069

    Article  CAS  PubMed  Google Scholar 

  42. Denise L, Ritiéle P, Angélica A, Emanuelle S, Jacqueline C, Vanusa M (2018) Extract of Citrus maxima (pummelo) leaves improve hepatoprotective activity in Wistar rats submitted to the induction of non-alcoholic hepatic steatosis. Biomed Pharmacother 98:338–346. https://doi.org/10.1016/j.biopha.2017.12.070

    Article  CAS  Google Scholar 

  43. Mariane R, Jéssica L, Carol C, Artur J, Fabiane V, Fabiana K, Cristina S, Dijon H, Cleverton R, Ana L, Camila R, Fernando M (2019) Lycopene modulates pathophysiological processes of non-alcoholic fatty liver disease in obese rats. Antioxidants 8(8):276–276. https://doi.org/10.3390/antiox8080276

    Article  CAS  Google Scholar 

  44. Moghaddam N, Seyed D, Mousavi S, Chiti H, Rasoulifard M, Pourmansouri Z (2021) Application of whey protein-alginate particles coated by black seed oil as a biocompatible carrier of quercetin at treating non-alcoholic fatty liver disease. J Funct Foods. https://doi.org/10.1016/j.jff.2021.104728

    Article  Google Scholar 

Download references

Acknowledgements

All the authors are grateful for the support mentioned in Funding.

Funding

This research was financially supported by the Doctoral Scientific Research Start-up Foundation of the Harbin University of Commerce (Grant Number 2019DS098), the Young Innovation Talents Project from the Harbin University of Commerce (grant number 2019CX31), and the Graduate Innovation Fund from the Harbin University of Commerce (grant number YJSCX2019–615HSD). Applied Technology Research and Development Program from Heilongjiang Provincial Department of Education (GA20B301).

Author information

Authors and Affiliations

Authors

Contributions

YQM and XW led the project, designed the study, interpreted the results, and revised the paper; WYX and QHY produced the experiments and collected the data; XW and WYX performed the data analyses and wrote the manuscript. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Yongqiang Ma or Xin Wang.

Ethics declarations

Competing interests

All authors state that they have no personal or financial conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ma, Y., Xiu, W., Wang, X. et al. Extraction of raspberry ketone from red raspberry and its intervention in the non-alcoholic fatty liver disease. Appl Biol Chem 65, 78 (2022). https://doi.org/10.1186/s13765-022-00745-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13765-022-00745-3

Keywords